A New Consensus Report on Biomarkers for the Early Antemortem Diagnosis of Alzheimer Disease: Current Status, Relevance to Drug Discovery, and Recommendations for Future Research | Zendy

AI Assistant Blog Pricing

A New Consensus Report on Biomarkers for the Early Antemortem Diagnosis of Alzheimer Disease: Current Status, Relevance to Drug Discovery, and Recommendations for Future Research

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.